id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-D-0187-0044,FDA,FDA-2000-D-0187,"Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria;
Guidance for Industry; Availability",Notice,Notice of Availability,2022-12-08T05:00:00Z,2022,12,2022-12-08T05:00:00Z,,2022-12-08T15:46:19Z,2022-26711,0,0,0900006485524919
FDA-2000-D-0187-0045,FDA,FDA-2000-D-0187,Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry - Final Guidance,Other,Guidance,2022-12-08T05:00:00Z,2022,12,2022-12-08T05:00:00Z,,2024-11-07T00:45:38Z,,1,0,090000648552199f